Biomarkers of hypercoagulability and inflammation in primary hyperparathyroidism

Medical Science Monitor

Volumn 14, Issue 12, 2008, Pages

  Chertok Shacham, Elena ^a   Ishay, Avraham ^a   Lavi, Idit ^b   Luboshitzky, Rafael ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

Atherosclerosis; Biomarkers of hypercoagulability; Hypercalcemia; Parathyroid; Primary hyperparathyroidism

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM; D DIMER; FIBRINOGEN; INTERLEUKIN 6; PARATHYROID HORMONE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCALCEMIA; HYPERCOAGULABILITY; INFLAMMATION; MALE; PRIMARY HYPERPARATHYROIDISM;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED;

EID: 57349126385     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hedback GM, Oden AS: Cardiovascular disease, hypertension and renal function in primary hyperparathyroidism. J Int Med, 2002; 251: 476-83
2. Stefenelli T, Abela C, Frank H et al: Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for Follow-Up. J Clin Endocrinol Metab, 1997; 82: 106-12
3. Rubin MR, Maurer MS, McMahon DJ et al: Arterial Stiffness in mild primary hyperparathyroidism. Clin Endocrinol Metab, 2005; 90: 3326-30
4. Nuzzo V, Tauchmanova L, Fonderico F et al: Increased intima-media thickness of carotid artery wall, normal blood pressure and normal ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol, 2002; 147: 453-59
5. Vestergaard P, Mollerlup CP, Frokjaer VG et al: Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg, 2003; 27: 216-22
6. De la Torre NG, Wass JAH, Turner HE: Parathyroid adenoma and cardiovascular risk. Endocr-Related Cancer, 2003; 10: 309-22
7. Taylor WH: The prevalence of diabetes mellitus in patients with primary hyperparathyroidism and among their relatives. Diab Med, 1991; 8: 683-87
8. Hagstrom E, Lundgren E, Lithell H et al: Normalized dyslipidemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol, 2002; 56: 253-60
9. Willerson JT, Ridker PM: Inflammation as a cardiovascular risk factor. Circulation, 2004; 109(Suppl.II): II-2-II-10
10. Diamant M, Lamb HJ, van de Ree MA et al: The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab, 2005; 90: 1595-601
11. Blankenberg S, McQueen MJ, Smieja M et al: Comparative impact of multiple biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation, 2006; 114: 201-8
12. Takeshita Y, Takamura T, Hamaguchi E et al: Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line. Metab, 2006; 55: 1464-72
13. Libby P, Simon DI: Inflammation and thrombosis: the clot thickens. Circulation, 2001; 103: 1718-20
14. Ehlermann P, Mirau W, Jahn J et al: Predictive value of inflammatory and haemostatic parameters, Atherosclerotic risk factors and Chest X-ray for aortic arch atheromatosis. Stroke, 2004; 35: 34-39
15. Smith A, Patterson C, Yarnell J, Rumley A: Which haemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation, 2005; 112: 3080-87
16. Yusuf S, Hawken S, Ounpuu S et al: Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet, 2005; 366: 1640-49
17. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults. JAMA, 2002; 287: 356-59
18. Danesh J, Lewington S, Thompson SG et al: Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA, 2005; 294: 1799-809
19. Margolis KL, Manson JE, Greenland P, Rodabough RG: Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med, 2005; 165: 500-8
20. st century. J Clin Endocrinol Metab, 2002; 87: 5353-61
21. Yamamoto K, Takeshita K, Kojima T et al: Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc Res, 2005; 66: 276-85
22. Kanaya AM, Wassel FC, Vittinghoff E et al: Arch Intern Med, 2006; 166: 350-56
23. Tofler GH, Massaro J, Levy D et al: Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study). Am J Cardiol, 2005; 96: 1280-83
24. Liang X, Kanjanabuch T, Mao SL et al: Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am J Physiol Endocrinol Metab, 2006; 290: E103-13
25. Ogard C, Engelmann M, Kistorp C et al: Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clin Endocrinol, 2005; 63: 493-98
26. Guo CY, Holland PA, Jackson BF et al: Immediate changes in biochemical markers of bone turnover and circulating interleukin-6 after parathyroidectomy for primary hyperparathyroidism. Eur J Endocrinol, 2000; 142: 451-59
27. Steffenelli T, Abela C, Frank H et al: Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up. J Clin Endocrinol Metab, 1997; 82: 106-12
28. Ozdogen M, Bozcuk H, Coban E: Low-grade inflammation in white-coat hypertension. Med Sci Monit, 2007; 13(12): CR570-73
29. Nuzzo V,Tauchmanova L, Fonderico F et al: Increased intima-media thickness of the carotid artery all, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol, 2002; 147: 453-59
30. Anderson P, Rydberg E, Willenheimer R: Primary hyperparathyroidism and heart disease - a review. Eur Heart J, 2004; 25: 1776-87
31. Rubin M, Maurer MS, McMahon DJ et al: Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab, 2005; 90: 3326-30
32. Saleh FN, Schirmet H, Sundsfjord J, Jorde R: Parathyroid hormone and left ventricular hypertrophy. Eur Heart J, 2003; 24: 2054-60
33. Nilsson IL, Rastad J, Johansson K, Lind L: Endothelial function and blood pressure response to local and systemic hypercalcemia. Surgery, 2001; 130: 986-90